Clinical Trial Update: Schizophrenic Patients Taking Part in Integrated Care Program

View source ↗

Summary

The AstraZeneca-sponsored clinical trial involving schizophrenia and related psychotic disorders has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delusional Disorder
• Psychotic Disorder Not Otherwise Specified
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Schizoaffective Disorder | Status: TERMINATED